Research location
New Brunswick
New Jersey, United States
Advertisement
Research activity in New Brunswick
New Jersey, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 708 trials and 784 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in New Brunswick
708 linked trials · page 3 of 15Diabetes Electronic Prompt for Improved Care Coordination and Treatment in the EDNCT06899191 · 2025-03-30 · 1 site observation
COMPLETED
Implementation of a Peer Leader-facilitated Dyadic InterventionNCT06643806 · 2025-03-20 · 1 site observation
COMPLETED
Comparative Effectiveness of Prophylactic ICD Versus Non-ICD TherapyNCT06543446 · 2025-03-04 · 1 site observation
TERMINATED
Testing Low Dose Tamoxifen for Invasive Breast Cancer, LoTam TrialNCT06671912 · 2025-02-19 · 1 site observation
SUSPENDED
Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic DiseaseNCT06760637 · 2025-01-06 · 2 site observations
ACTIVE_NOT_RECRUITING
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the BrainNCT06500455 · 2024-12-12 · 1 site observation
ACTIVE_NOT_RECRUITING
A Trial of AN0025 With Chemoradiation Therapy in Stage III NSCLC ParticipantsNCT05358691 · 2024-11-01 · 1 site observation
WITHDRAWN
A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast CancerNCT06568692 · 2024-10-02 · 1 site observation
TERMINATED
Open-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma.NCT06473779 · 2024-09-30 · 1 site observation
ACTIVE_NOT_RECRUITING
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC PatientsNCT06538038 · 2024-09-17 · 1 site observation
ACTIVE_NOT_RECRUITING
ABA-101 in Participants With Progressive Multiple SclerosisNCT06566261 · 2024-09-11 · 1 site observation
ACTIVE_NOT_RECRUITING
Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Breast Cancer, When Given in Combination With ChemotherapyNCT06449222 · 2024-08-26 · 1 site observation
ACTIVE_NOT_RECRUITING
HomeStyles-Adults of Chinese HeritageNCT06136793 · 2024-08-25 · 1 site observation
ENROLLING_BY_INVITATION
A Study to Evaluate Solrikitug in Participants With COPD (ZION)NCT06496620 · 2024-08-14 · 1 site observation
ACTIVE_NOT_RECRUITING
Aim 3, Adapting and Implementing Evidence-based Breast Cancer Follow-up in Primary CareNCT05400941 · 2024-06-24 · 1 site observation
ENROLLING_BY_INVITATION
Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide and DurvalumabNCT06211036 · 2024-06-05 · 1 site observation
ACTIVE_NOT_RECRUITING
Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II DiabetesNCT06267391 · 2024-05-01 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of BB-1701 in Previously Treated Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive or HER2-low Unresectable or Metastatic Breast CancerNCT06188559 · 2024-04-10 · 1 site observation
COMPLETED
A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)NCT06223360 · 2024-03-28 · 1 site observation
ACTIVE_NOT_RECRUITING
Postprandial Inflammation and Nuts (PIN) in Older AdultsNCT06348771 · 2024-03-25 · 2 site observations
COMPLETED
Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer SurvivorsNCT05896189 · 2024-02-29 · 1 site observation
ACTIVE_NOT_RECRUITING
Sistas Informing Sistas on Topics About AIDS and Prevention (SISTA-P)NCT06307028 · 2024-01-08 · 1 site observation
COMPLETED
Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple SclerosisNCT06141473 · 2023-12-13 · 1 site observation
ACTIVE_NOT_RECRUITING
ONC-392 Plus Lutetium Lu 177 Vipivotide Tetraxetan in Patients With mCRPCNCT05682443 · 2023-12-11 · 1 site observation
ACTIVE_NOT_RECRUITING
IMM60 and Pembrolizumab in Melanoma and NSCLCNCT05709821 · 2023-11-15 · 1 site observation
TERMINATED
A Phase III Randomised Study to Evaluate Dato-DXd and Durvalumab for Neoadjuvant/Adjuvant Treatment of Triple-Negative or Hormone Receptor-low/HER2-negative Breast CancerNCT06112379 · 2023-11-14 · 1 site observation
ACTIVE_NOT_RECRUITING
Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced CancersNCT05891171 · 2023-10-13 · 1 site observation
ACTIVE_NOT_RECRUITING
OCTANE: Adjuvant Liposomal Doxorubicin and Carboplatin for Early-stage Triple-negative Breast CancerNCT05949021 · 2023-10-07 · 2 site observations
ACTIVE_NOT_RECRUITING
Pilot Testing Dementia-Enhanced Training and Tool for Home Hospice CliniciansNCT05719077 · 2023-10-06 · 1 site observation
COMPLETED
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)NCT05952557 · 2023-10-05 · 1 site observation
ACTIVE_NOT_RECRUITING
Study of Favezelimab Coformulated With Pembrolizumab (MK-4280A) in Participants With Selected Solid Tumors (MK-4280A-010)NCT06036836 · 2023-09-29 · 1 site observation
COMPLETED
Choices About Genetic Testing And Learning Your Risk With Smart TechnologyNCT06184867 · 2023-09-26 · 1 site observation
COMPLETED
Study of Chemotherapy Plus Ipatasertib for People With Solid Tumors With PTEN/AKT Mutations, A ComboMATCH Treatment TrialNCT05554380 · 2023-09-22 · 1 site observation
ACTIVE_NOT_RECRUITING
Study of MK-0472 in Participants With Advanced/Metastatic Solid Tumors (MK-0472-001)NCT05853367 · 2023-07-06 · 1 site observation
ACTIVE_NOT_RECRUITING
Study of PULSAR-ICI +/- IMSA101 in Patients With Oligometastatic NSCLC and RCCNCT05846646 · 2023-06-28 · 1 site observation
TERMINATED
HB-302/HB-301 Therapy in Participants With Metastatic Castration-Resistant Prostate CancerNCT05553639 · 2023-05-23 · 1 site observation
TERMINATED
HomeStyles-2: Shaping HOME Environments and LifeSTYLES to Prevent Childhood ObesityNCT04802291 · 2023-05-15 · 1 site observation
COMPLETED
Acute Exercise on Brain Insulin SensitivityNCT05853913 · 2023-05-11 · 3 site observations
COMPLETED
Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer Who Have Received Endocrine TherapyNCT05840211 · 2023-05-08 · 1 site observation
ACTIVE_NOT_RECRUITING
Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in GBA-PDNCT05819359 · 2023-03-31 · 1 site observation
ACTIVE_NOT_RECRUITING
Safety and Effectiveness of ABM-168 in Adults with Advanced Solid Tumors.NCT05831995 · 2023-03-30 · 1 site observation
TERMINATED
Monitoring Symptoms to Help Young Women Take Hormone Therapy for Stage I-III Breast Cancer, ASPEN StudyNCT05568472 · 2023-03-29 · 1 site observation
ACTIVE_NOT_RECRUITING
First-in-Human Study of RLY-5836 in Advanced Breast Cancer and Other Solid TumorsNCT05759949 · 2023-03-29 · 1 site observation
COMPLETED
Ramucirumab Plus Pembrolizumab vs Usual Care for Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer Following Immunotherapy, Pragmatica-Lung StudyNCT05633602 · 2023-03-14 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma.NCT05763121 · 2023-01-30 · 1 site observation
TERMINATED
Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast CancerNCT05563220 · 2023-01-24 · 1 site observation
ACTIVE_NOT_RECRUITING
Understanding the Role of Gut Microbiota in Hyperphagia in Prader-Willi SyndromeNCT05541003 · 2023-01-06 · 1 site observation
COMPLETED
A Study Evaluating AB248 Alone or in Combination With Pembrolizumab in Adult Patients With Solid TumorsNCT05653882 · 2023-01-04 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Investigate LYL845 in Adults With Solid TumorsNCT05573035 · 2022-12-19 · 1 site observation
TERMINATED
Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung CancerNCT05198830 · 2022-12-15 · 1 site observation
ACTIVE_NOT_RECRUITING
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.